banner https://www.profitablecpmrate.com/nsirjwzb79?key=c706907e420c1171a8852e02ab2e6ea4

Earnings Summary: Dell Technologies (DELL) Q1 2026 revenue up 5%

Dell Technologies (NYSE: DELL) has announced financial results for the first quarter of fiscal 2026, reporting a double-digit increase in adjusted earnings. Dell’s first-quarter 2026 revenue increased 5% year-over-year to $23.4 billion Infrastructure Solutions Group revenue grew 12% in Q1; Client Solutions Group revenue rose 5% On a per-share basis, Q1 profit was $1.37, flat … Read more

Earnings Summary: CooperCompanies (COO) reports higher Q2 revenue and profit

Medical device maker CooperCompanies (NYSE: COO) has reported an increase in adjusted earnings for the second quarter of 2025, aided by a 6% revenue growth. CooperComapanies second-quarter revenue increased 6% year-over-year to $1.0 billion, up 7% in constant currency CooperVision revenue rose 5% to $669.6 million in Q2; CooperSurgical revenue moved up 8% to $332.7 … Read more

BioLineRx Soars on Pancreatic Cancer Trial Buzz: What’s Driving the Surge?

The Big News Shaking Up BLRX BioLineRx (NASDAQ: BLRX), a scrappy biopharmaceutical player out of Israel, is stealing the spotlight today, and for good reason. The company just dropped a bombshell announcement: new data from the pilot phase of its CheMo4METPANC Phase 2 trial for pancreatic cancer is headed to the American Society of Clinical … Read more

Vivakor’s Special Dividend Sparks 40% Surge: What’s Driving VIVK’s Big Day?

Alright, folks, let’s talk about a stock that’s got the market buzzing like a beehive today—Vivakor, Inc. (NASDAQ: VIVK). As of this writing, VIVK is up a whopping 40% in pre-market trading, and it’s not hard to see why. The company just dropped a bombshell announcement that’s got investors scrambling to hit the buy button: … Read more

Ulta Beauty (ULTA) Earnings: 1Q25 Key Numbers

Ulta Beauty, Inc. (NASDAQ: ULTA) reported its earnings results for the first quarter of 2025. Net sales increased 4.5% year-over-year to $2.8 billion.   Comparable sales increased 2.9%. Net income was $305.1 million, or $6.70 per share, compared to $313.1 million, or $6.47 per share, last year. For fiscal year 2025, Ulta expects net sales … Read more

Costco (COST) Q3 2025 earnings beat estimates; sales up 8%

Warehouse giant Costco Wholesale Corporation (NASDAQ: COST) reported an increase in profit for the third quarter of 2025, driven by strong sales growth. Earnings also beat estimates. Revenues rose to $63.2 billion in the May quarter from $58.5 billion in the corresponding period last year. Total comparable store sales grew 5.7% year-over-year, and e-commerce sales … Read more

Kohl’s Corporation reports narrower net loss for Q1 2025; sales down 4%

Kohl’s Corporation (NYSE: KSS) reported a narrower net loss for the first quarter of 2025. The department store chain’s net sales decreased 4% in Q1. Net sales declined 4% year-over-year to $3.0 billion in the first three months of fiscal 2025. Comparable store sales dropped 3.9%. The company reported a net loss of $15 million … Read more

Costco Q3 2025 Earnings: Stay tuned for the live earnings call and real-time transcript

Costco Wholesale Corporation (NASDAQ: COST) will report financial results for the third quarter of 2025 today after markets close. Listen to Costco’s earnings call live and check the real-time transcript Wall Street will be looking for earnings of $4.23 per share for Q3 FY25, which represents a 12% growth from the same period last year. … Read more

Key takeaways from Hormel Foods’ (HRL) Q2 2025 earnings report

Shares of Hormel Foods Corporation (NYSE: HRL) turned green in midday trade on Thursday although the company delivered mixed results for the second quarter of 2025 and narrowed its guidance for the full year. While sales were up slightly compared to the year-ago period, earnings witnessed a decline. The branded foods provider anticipates strong growth … Read more

Alzamend Neuro Soars on Breakthrough Trial News: Is This Biotech Stock a Hidden Gem?

Alright, folks, buckle up because we’re diving into the wild world of biotech stocks, and today, one name is lighting up the market like a Fourth of July fireworks show: Alzamend Neuro, Inc. (NASDAQ: ALZN). As of this writing, ALZN is screaming higher in pre-market trading, up a jaw-dropping 139%—and for good reason! The company … Read more

banner banner https://www.profitablecpmrate.com/nsirjwzb79?key=c706907e420c1171a8852e02ab2e6ea4